VRNA - Verona Pharma plc Trailing Twelve Months Revenue Growth

Graphic logo of Verona Pharma Inc. (VRNA)

Verona Pharma plc (VRNA) focuses on the therapy of severe respiratory pathologies, penetrating the stable COPD market. The primary challenge remains the pace of commercial adoption for its new product. Patent exclusivity of the molecule serves as a defense against pressure from industry behemoths. Analyzing the current sales growth rate over a rolling 12-month period year-over-year on GURU.Markets, we see that -98.90 reflects the latest value of the metric.

VRNA - Verona Pharma plc Sales Growth YoY (Last Twelve Months) over the range 02/11/2024 - 02/20/2024

veronapharma.com (VRNA) - metric breakdowns and financial figures

- stock price and consensus target price:
Fundamental company valuation:Verona Pharma Inc.
Flagship merchandise of Verona Pharma plc

Verona Pharma plc (VRNA) operates in the high-risk inhalation drug segment, which is dominated by behemoths with colossal budgets. The rolling year revenue dynamics quantify the company's resilience against competitors by measuring the acceleration vector of core earnings and the impact of currency fluctuations, allowing the LTM sales volume growth chart to identify trend reversals in a timely manner and avoid overpayment.

Competitors of Verona Pharma plc (VRNA)

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth jyongbio.com|LGND: Sales Growth YoY (TTM)|Sales Growth YoY (Last 12 Months) AMRX|Sales Growth YoY (Last Twelve Months) Perrigo Company|Trailing Twelve Months Revenue Growth Alvotech ALVO|Sales Growth YoY (TTM) LQDA|GLPG: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ANIP (ANI Pharmaceuticals, Inc.)|Annual Revenue Growth (Last Twelve Months) MannKind Corp (MNKD)|AMPH: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last 12 Months) TBPH|AQST (Aquestive Corp) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) scPharmaceuticals Inc. (SCPH)|Revenue Growth YoY (Last 12 Months) TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) SXT Pharmaceuticals SXTC|Revenue Dynamics YoY (Last Twelve Months) EPRX|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)